首页|缬沙坦胶囊联合硝苯地平控释片治疗高血压患者对其血压水平的影响

缬沙坦胶囊联合硝苯地平控释片治疗高血压患者对其血压水平的影响

扫码查看
目的 分析缬沙坦胶囊与硝苯地平控释片联合用药方案对高血压患者产生的影响.方法 方便选取2021年4月—2023年4月福建省永泰县医院收治的102例高血压患者为研究对象,按随机数表法分为参照组(缬沙坦胶囊单一疗法)、研究组(硝苯地平控释片+缬沙坦胶囊联合疗法),各51例.比较两组临床治疗有效率、心率、血压、不良反应.结果 研究组临床治疗有效率为96.08%,较参照组的84.31%更高,差异有统计学意义(χ2=3.991,P=0.046).治疗后,研究组心率(84.98±6.22)次/min,较参照组的(89.69±6.34)次/min更低,研究组舒张压(82.12±3.22)mmHg,低于参照组的(86.35±3.41)mmHg,收缩压(122.12±4.11)mmHg,低于参照组的(135.41±3.31)mmHg,差异有统计学意义(P均<0.05).研究组不良反应发生率为 5.88%,较参照组的19.61%更低,差异有统计学意义(χ2=4.320,P=0.038).结论 缬沙坦胶囊联合硝苯地平控释片具有显著治疗效果,可在安全性前提下有效控制血压.
Effect of Valsartan Capsule Combined with Nifedipine Controlled Release Tablets on Blood Pressure in Patients with Hypertension
Objective To analyze the effect of combination of valsartan capsule and nifedipine controlled release tab-lets on patients with hypertension.Methods 102 hypertensive patients admitted to Yongtai County Hospital in Fujian Province from April 2021 to April 2023 were conveniently selected as study subjects,and were divided into the refer-ence group(valsartan capsule monotherapy)and the study group(nifedipine controlled-release tablets + valsartan cap-sule combination therapy)according to the method of randomized numerical table,each with 51 cases.Compared the clinical treatment efficiency,heart rate,blood pressure,and adverse reactions of the two groups.Results The clinical treatment efficiency of the study group was 96.08%,which was higher than the 84.31%of the reference group,and the difference was statistically significant(χ2=3.991,P=0.046).After treatment,the heart rate of the study group(84.98±6.22)beats/min was lower than that of the reference group(89.69±6.34)beats/min,the diastolic blood pressure of the study group(82.12±3.22)mmHg was lower than that of the reference group(86.35±3.41)mmHg,and the systolic blood pressure(122.12±4.11)mmHg was lower than that of the reference group(135.41±3.31)mmHg,and the differ-ences were statistically significant(all P<0.05).The incidence of adverse reactions in the study group was 5.88%,which was lower than the 19.61%in the reference group,and the difference was statistically significant(χ2=4.320,P= 0.038).Conclusion Valsartan capsule combined with nifedipine controlled release tablets has significant therapeutic effect,and can effectively control blood pressure under the premise of safety.

Valsartan capsuleNifedipine controlled release tabletHypertension

邱维芳、张贤桂、黄为添、鲍贵峰

展开 >

福建省永泰县医院药剂科,福建福州 350700

福建省永泰县医院内科,福建福州 350700

缬沙坦胶囊 硝苯地平控释片 高血压

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(3)
  • 18